高水平的甘油三会增加糖尿病微血管并发症的风险:一个横截面研究
Jiahang Li1, Lei Shi1, Guohong Zhao2
1Department of Pharmacy, Tangdu Hospital of Air Force Medical University, Xi'an, 710038, China.
高水平的甘油三显著增加了糖尿病微血管并发症的风险,如视网膜病变和病变. 患有2型糖尿病的患者应严格控制脂质水平,特别是如果年龄较大或疾病持续时间较长.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 糖尿病学 糖尿病学
背景情况:
- 在2型糖尿病 (T2DM) 中,微血管并发症的患病率增加.
- 关于脂质谱对这些并发症的具体影响的持续辩论.
研究的目的:
- 研究2型糖尿病患者的脂质配置和微血管并发症的发展之间的相关性.
- 为了确定与风险增加相关的特定脂质参数.
主要方法:
- 这是一项涉及1096名T2DM患者的回顾性横截面研究.
- 将其分类为控制,糖尿病视网膜病变 (DR),病变 (DKD) 和外围神经病变 (DPN) 组.
- 分析脂质概况和后勤回归以评估并发症风险.
主要成果:
- 糖尿病微血管并发症组与对照组相比,显示出更高的失脂血症率.
- 升高的甘油三 (TG) 水平与增加的并发症数量有显著的相关性.
- 高TG水平被确定为DKD,DR和DPN的危险因素 (ORs在2.252至2.447之间).
- 在55岁以上,T2DM持续时间>10年,HbA1c≥7%的患者中观察到DKD,DR和DPN高TG的风险增加.
结论:
- 高甘油水平是糖尿病微血管并发症的重要危险因素.
- 患有T2DM的患者,特别是那些年龄较大,疾病持续时间较长或HbA1c较高的患者,需要更严格的脂质管理.
- 这些发现强调了脂质谱监测在T2DM管理中的重要性,以预防并发症.
更多相关视频
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Diabetes: Symptoms, Diagnosis, and Complications
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
